Renal news roundup from AKF
Loading...
61 Results
Innovation in Renal Care
Vertex Pharmaceuticals is now evaluating its oral candidate inaxaplin in a Phase 3 trial to treat APOL1-mediated kidney disease (AMKD). The trial will assess in...
Research News
The United Network for Organ Sharing evaluated the medical records of Black kidney transplant candidates after the National Kidney Foundation and the American S...
Research News
Researchers found that the strongest markers of kidney failure risk were high blood creatinine levels and kidney biopsy results for patients with antineutrophil...
Research News
Scientists have discovered that Akkermansia muciniphila is capable of modifying antibodies in the gut microbiome by stripping the sugar coating from immunoglobu...
Policy Watch
Akebia Therapeutics' once-daily oral drug Vafseo, or vadadustat, has gained FDA approval as a treatment for anemia caused by chronic kidney disease in adul...
Policy Watch
The FDA has granted clearance to Calyxo for the redesigned version of its CVAC system. The system removes kidney stones using aspiration and irrigation. MassDev...
Opinion, Commentary and Analysis
Tiffany Ferguson, a member of the American College of Physician Advisors' Observation Subcommittee, analyzes a report on the CMS' End-Stage Renal Dise...
Patient Perspective
Over 100,000 people are waiting for an organ transplant, according to The American Kidney Fund (AKF), including 10-year-old Jayden Williams, who has been on dia...
Innovation in Renal Care
Massachusetts General Hospital announced the successful completion of the first pig-to-human kidney transplant received by a 62-year-old man with end-stage rena...